Preventing coronary occlusion in an elderly severe aortic stenosis patient with critically low coronary heights

Abstract

Transcatheter aortic valve replacement (TAVR) is an established treatment for severe, symptomatic aortic stenosis (AS). However, the presence of low coronary heights confers a high risk for coronary obstruction during or after TAVR.